Topics

Dechra Pharmaceuticals revenue growth slows slightly in second half

05:08 EDT 9 Jul 2019 | Proactive Investors

Revenues in the 12 months to end-June were up 17% on the previous year, which was slower than the 19.1% seen in the first six months

Original Article: Dechra Pharmaceuticals revenue growth slows slightly in second half

NEXT ARTICLE

More From BioPortfolio on "Dechra Pharmaceuticals revenue growth slows slightly in second half"

Quick Search